BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 23448792)

  • 1. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
    Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
    Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
    Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
    Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
    Aliment Pharmacol Ther; 2022 Oct; 56(7):1168-1182. PubMed ID: 35916190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
    Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of colorectal cancer is related to frequent hospitalization of IBD in an Asian population: results from a nationwide study.
    Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Liao SC; Kao CH
    QJM; 2015 Jun; 108(6):457-63. PubMed ID: 25362095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
    Jess T; Riis L; Vind I; Winther KV; Borg S; Binder V; Langholz E; Thomsen OØ; Munkholm P
    Inflamm Bowel Dis; 2007 Apr; 13(4):481-9. PubMed ID: 17206705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
    Weimers P; Ankersen DV; Løkkegaard ECL; Burisch J; Munkholm P
    Inflamm Bowel Dis; 2021 Oct; 27(11):1795-1803. PubMed ID: 33409534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
    Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
    Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    Wijnands AM; de Jong ME; Lutgens MWMD; Hoentjen F; Elias SG; Oldenburg B;
    Gastroenterology; 2021 Apr; 160(5):1584-1598. PubMed ID: 33385426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the risk of colorectal cancer in inflammatory bowel disease decreased?
    Andersen NN; Jess T
    World J Gastroenterol; 2013 Nov; 19(43):7561-8. PubMed ID: 24282346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.